Liver-Expressed antimicrobial peptide as an early predictor of dysplasia in oral submucous fibrosis: An experimental trial
Background: Liver-expressed antimicrobial peptide 1(LEAP1) plays a major role in dysplasia. Oral potentially malignant disorders (OPMDs) are on the rise, and the rate of malignant transformation is alarming. Iron (Fe) deficiency in anemia of chronic disease may be because of the presence of oral sub...
Main Authors: | Tejavathi Nagaraj, Bhavana T Veerabasavaiah, H N Santosh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Indian Academy of Oral Medicine and Radiology |
Subjects: | |
Online Access: | http://www.jiaomr.in/article.asp?issn=0972-1363;year=2022;volume=34;issue=3;spage=268;epage=271;aulast=Nagaraj |
Similar Items
-
Efficacy of pentoxifylline in the management of oral submucous fibrosis
by: Santosh Patil, et al.
Published: (2014-01-01) -
Oral Submucous Fibrosis- Correlation between Clinical Findings and Histopathological Grading
by: K. Prabhu, et al.
Published: (2018-08-01) -
Oral Submucous Fibrosis- Correlation between Clinical Findings and Histopathological Grading
by: K Prabhu, et al.
Published: (2020-07-01) -
Haemoglobin levels in patients with Oral Submucous Fibrosis
by: Lavina Taneja, et al.
Published: (2007-01-01) -
Expression of connexin43 in oral submucous fibrosis, oral epithelial dysplasia and oral squamous cell carcinoma: A cross-sectional immunohistochemical study
by: Raghavelu Narendran Mugundan, et al.
Published: (2023-01-01)